Pembrolizumab plus best supportive care versus placebo plus best supportive care as second-line therapy in patients in Asia with advanced hepatocellular carcinoma (HCC): Phase 3 KEYNOTE-394 study

被引：91
|
作者：
Qin, Shukui
Chen, Zhendong
Fang, Weijia
Ren, Zhenggang
Xu, Ruocai
Ryoo, Baek-Yeol
Meng, Zhiqiang
Bai, Yuxian
Chen, Xiaoming
Liu, Xiufeng
Xiao, Juxiang
Ho, Gwo Fuang
Mao, Yimin
Ye, Xing
Ying, Jieer
Li, Jianfeng
Zhong, Wen Yan
Zhou, Yu
Siegel, Abby B.
Hao, Chunyi
机构：
[1] Nanjing Chinese Med Univ, Jinling Hosp, Ctr Canc, Nanjing, Peoples R China
[2] Anhui Med Univ, Hosp 2, Hefei, Peoples R China
[3] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
[5] Hunan Canc Hosp, Changsha, Peoples R China
[6] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[7] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[8] Harbin Med Univ, Canc Hosp, Dept Med Oncol, Harbin, Peoples R China
[9] Guangdong Prov Peoples Hosp, Dept Intervent Radiol, Guangzhou, Peoples R China
[10] Chinese PLA, Eastern Theater Gen Hosp, Nanjing, Peoples R China
[11] Xi An Jiao Tong Univ, Affiliated Hosp 1, Shaaxi, Peoples R China
[12] Univ Malaya, Dept Clin Oncol, Fac Med, Kuala Lumpur, Malaysia
[13] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai, Peoples R China
[14] Deyang Hosp, Deyang, Peoples R China
[15] Chinese Acad Sci, Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp,Inst Canc & Basic Med IBMC, Hangzhou, Zhejiang, Peoples R China
[16] MSD China, Beijing, Peoples R China
[17] MSD China, Shanghai, Peoples R China
[18] Columbia Univ, New York, NY USA
[19] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.383
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
383
引用
收藏
页数：3
相关论文
共 50 条
  • [21] A randomized phase 3 study of maintenance therapy with S-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L)
    Tanaka, Kaoru
    Morita, Satoshi
    Ando, Masahiko
    Yokoyama, Takuma
    Nakamura, Atsushi
    Yoshioka, Hiroshige
    Ishiguro, Takashi
    Miura, Satoru
    Toyozawa, Ryo
    Oguri, Tetsuya
    Daga, Haruko
    Ko, Ryo
    Bessho, Akihiro
    Tachihara, Motoko
    Iwamoto, Yasuo
    Hirano, Katsuya
    Nakanishi, Yoichi
    Nakagawa, Kazuhiko
    Yamamoto, Nobuyuki
    Okamoto, Isamu
    CANCER, 2020, 126 (16) : 3648 - 3656
  • [22] A RETROSPECTIVE ANALYSIS OF SECOND-LINE CHEMOTHERAPY VERSUS BEST SUPPORTIVE CARE (BSC) IN PATIENTS WITH ADVANCED GASTRIC CANCER (AGC)
    Park, S. H.
    Kim, Y. S.
    Hong, J.
    Sym, S. J.
    Cho, E. K.
    Shin, D. B.
    ANNALS OF ONCOLOGY, 2008, 19 : 176 - 176
  • [23] Best supportive care in combination with polychemotherapy versus best supportive care alone as second-line therapy in stage IV metastatic melanoma (DeCOG MM-PAL 8)
    Ulrich, J.
    Trefzer, U.
    Tilgen, W.
    Schadendorf, D.
    Kaatz, M.
    Mohr, P.
    Garbe, C.
    Hauschild, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Oxaliplatin/folinic acid/5-fluorouracil [24h] (OFF) plus best supportive care versus best supportive care alone (BSC) in second-line therapy of gemcitabine-refractory advanced pancreatic cancer (CONKO 003).
    Oettle, H
    Pelzer, U
    Stieler, J
    Hilbig, A
    Roll, L
    Schwaner, I
    Adler, M
    Detken, S
    Dörken, B
    Riess, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 315S - 315S
  • [25] Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma
    Grivas, Petros
    Kopyltsov, Evgeny
    Su, Po-Jung
    Parnis, Francis X.
    Park, Se Hoon
    Yamamoto, Yoshiaki
    Fong, Peter C.
    Tournigand, Christophe
    Duran, Miguel A. Climent
    Bamias, Aristotelis
    Caserta, Claudia
    Chang, Jane
    Cislo, Paul
    di Pietro, Alessandra
    Wang, Jing
    Powles, Thomas
    EUROPEAN UROLOGY, 2023, 83 (04) : 320 - 328
  • [26] Rationale and Design for the LUME-Colon 1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Nintedanib Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Patients With Advanced Colorectal Cancer Refractory to Standard Treatment
    Van Cutsem, Eric
    Yoshino, Takayuki
    Hocke, Julia
    Oum'Hamed, Zohra
    Studeny, Matus
    Tabernero, Josep
    CLINICAL COLORECTAL CANCER, 2016, 15 (01) : 91 - 94
  • [27] Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial
    Paz-Ares, Luis
    de Marinis, Filippo
    Dediu, Mircea
    Thomas, Michael
    Pujol, Jean-Louis
    Bidoli, Paolo
    Molinier, Olivier
    Sahoo, Tarini Prasad
    Laack, Eckart
    Reck, Martin
    Corral, Jesus
    Melemed, Symantha
    John, William
    Chouaki, Nadia
    Zimmermann, Annamaria H.
    Visseren-Grul, Carla
    Gridelli, Cesare
    LANCET ONCOLOGY, 2012, 13 (03): : 247 - 255
  • [28] Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer
    Middleton, Gary
    Gridelli, Cesare
    De Marinis, Filippo
    Pujol, Jean-Louis
    Reck, Martin
    Ramlau, Rodryg
    Parente, Barbara
    Pieters, Thierry
    Visseren-Grul, Carla M.
    San Antonio, Belen
    John, William J.
    Zimmermann, Annamaria Hayden
    Chouaki, Nadia
    Paz-Ares, Luis
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (05) : 865 - 871
  • [29] AVELUMAB FIRST-LINE MAINTENANCE PLUS BEST SUPPORTIVE CARE VS BEST SUPPORTIVE CARE ALONE FOR ADVANCED UROTHELIAL CARCINOMA: ANALYSIS OF TIME TO END OF NEXT-LINE THERAPY IN JAVELIN BLADDER 100
    Grivas, Petros
    Park, Se Hoon
    Voog, Eric
    Kopyltsov, Evgeny
    Gurney, Howard
    Borges Muniz, David Queiroz
    Rolland, Frederic
    Als, Anne Birgitte
    Valderrama, Begona P.
    Wang, Jing
    Costa, Nuno
    Laliberte, Robert J.
    di Pietro, Alessandra
    Powles, Thomas
    Bellmunt, Joaquim
    JOURNAL OF UROLOGY, 2021, 206 : E765 - E765
  • [30] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma: analysis of time to end of next-line therapy in JAVELIN Bladder 100
    Grivas, Petros
    Park, Se Hoon
    Voog, Eric
    Kopyltsov, Evgeny
    Gurney, Howard
    Muniz, Queiroz Borges David
    Rolland, Frederic
    Als, Anne Birgitte
    Valderrama, Begona
    Wang, Jing
    Costa, Nuno
    Laliberte, Robert
    di Pietro, Alessandra
    Powles, Thomas
    Bellmunt, Joaquim
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 45 - 45
12345